Katrin Kupas

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Systematic review and network meta-analysis of the efficacy, safety and tolerability of xanomeline plus trospium chloride compared with eight oral antipsychotics for the acute treatment of schizophrenia.

Systematic review and network meta-analysis of the efficacy, safety and tolerability of xanomeline plus trospium chloride compared with eight oral antipsychotics for the acute treatment of schizophrenia.

Journal: Journal of comparative effectiveness research

Published: July 30, 2026

A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma.

A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: May 09, 2022

Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma.

Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 10, 2021

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risks.

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)-estimation of adverse event risks.

Journal: Trials

Published: September 08, 2020

Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma.

Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 31, 2020

On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies.

On estimands and the analysis of adverse events in the presence of varying follow-up times within the benefit assessment of therapies.

Journal: Pharmaceutical statistics

Published: May 03, 2018

Effects of Tiotropium on Exacerbations in Patients with COPD with Low or High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT® Trial.

Effects of Tiotropium on Exacerbations in Patients with COPD with Low or High Risk of Exacerbations: A Post-Hoc Analysis from the 4-Year UPLIFT® Trial.

Journal: Chronic obstructive pulmonary diseases (Miami, Fla.)

Published: March 27, 2015

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®).

Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®).

Journal: Advances in therapy

Published: February 18, 2015

The effect of safinamide, a novel drug for Parkinson's disease, on pressor response to oral tyramine: a randomized, double-blind, clinical trial.

The effect of safinamide, a novel drug for Parkinson's disease, on pressor response to oral tyramine: a randomized, double-blind, clinical trial.

Journal: Clinical pharmacology and therapeutics

Published: September 06, 2012

Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects.

Absolute Bioavailability and Effect of Food on the Disposition of Safinamide Immediate Release Tablets in Healthy Adult Subjects.

Journal: Clinical pharmacology in drug development

Published: April 09, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026